Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
Holding HRMY?
Track your performance easily

Harmony Biosciences Holdings (HRMY) Ownership - Who Owns Harmony Biosciences Holdings?

208 Followers

Harmony Biosciences Holdings (HRMY) Ownership Overview

26.73%18.33%1.74%21.67%31.52%
26.73% Insiders
1.74% Other Institutional Investors
21.67% ETFs
31.52% Public Companies and Individual Investors
The ownership structure of Harmony Biosciences Holdings (HRMY) stock is a mix of institutional, retail, and individual investors. Approximately 41.74% of the company’s stock is owned by Institutional Investors, 26.73% is owned by Insiders, and 31.52% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 05, 2024
xxxxxxxxxxxxx
$139380000
Nov 05, 2024
xxxxxxxxxxxxx
$139380000

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,618,033Insider11.60%238,778,631
6,051,120Insider10.61%218,324,410
4,260,835Institution7.47%153,730,927
3,129,795Institution5.49%112,923,004
2,686,298Institution4.71%96,921,632
2,648,255Institution4.64%95,549,040
2,571,024Insider4.51%92,762,546
1,888,549Institution3.31%68,138,848
811,814Institution1.42%29,290,249
665,829Institution1.17%24,023,110

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,686,298Institution4.71%96,921,632
2,648,255Institution4.64%95,549,040
478,696Institution0.84%17,271,352
441,871Institution0.77%15,942,706
402,677Institution0.71%14,528,586
350,035Institution0.61%12,629,263
339,616Institution0.60%12,253,345
318,627Institution0.56%11,496,062
262,884Institution0.46%9,484,855
251,671Institution0.44%9,080,290

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,421,739Institution4.25%87,376,343
1,887,323Institution3.31%65,886,446
992,877Institution1.74%39,715,080
783,597Institution1.37%31,343,880
822,744Institution1.44%29,684,604
743,398Institution1.30%25,952,024
462,777Institution0.81%18,511,080
431,526Institution0.76%17,261,040
341,463Institution0.60%11,920,473
333,455Institution0.58%11,640,914

FAQ

Who Owns Harmony Biosciences Holdings (HRMY)?
According to the latest TipRanks data, approximately 1.74% of the company's stock is held by institutional investors, 26.73% is held by insiders, and 31.52% is held by retail investors.
    What percentage of Harmony Biosciences Holdings (HRMY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.74% of Harmony Biosciences Holdings (HRMY) stock is held by institutional investors.
      What percentage of Harmony Biosciences Holdings (HRMY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 31.52% of Harmony Biosciences Holdings (HRMY) stock is held by retail investors.
        Who owns the most shares of Harmony Biosciences Holdings (HRMY)?
        Valor IV Pharma Holdings, LLC owns the most shares of Harmony Biosciences Holdings (HRMY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis